Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1–42 levels in APPV717I transgenic mice-Reference-Cited by-同舟云学术

Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1–42 levels in APPV717I transgenic mice

Published:2005-04-07 Issue:6 Volume:128 Page:1442-1453
ISSN:1460-2156
Container-title:Brain
language:en
Short-container-title:

Author:

Heneka Michael T.,Sastre Magdalena,Dumitrescu-Ozimek Lucia,Hanke Anne,Dewachter Ilse,Kuiperi Cuno,O'Banion Kerry,Klockgether Thomas,Van Leuven Fred,Landreth Gary E.

Publisher

Oxford University Press (OUP)

Subject

Neurology (clinical)

Link

http://academic.oup.com/brain/article-pdf/128/6/1442/1190196/awh452.pdf

Reference72 articles.

1. Aisen PS. Evaluation of selective COX-2 inhibitors for the treatment of Alzheimer's disease. J Pain Symptom Manag2002; 23: S35–40.

2. Aisen PS, Schafer KA, Grundman M, et al. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. J Am Med Assoc2003; 289: 2819–26.

3. Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimer's disease. Neurobiol Aging2000; 21: 383–421.

4. Alafuzoff I, Overmyer M, Helisalmi S, Soininen H. Lower counts of astroglia and activated microglia in patients with Alzheimer's disease with regular use of non-steroidal anti-inflammatory drugs. J Alzheimers Dis2000; 2: 37–46.

5. Bannwarth B, Lapicque F, Pehourcq F, et al. Stereoselective disposition of ibuprofen enantiomers in human cerebrospinal fluid. Br J Clin Pharmacol1995; 40: 266–9.

Cited by 511 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing antidiabetic drugs for Alzheimer's disease: A review of preclinical and clinical evidence and overcoming challenges;Life Sciences;2024-10

2. PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease;Medicinal Chemistry;2024-10

3. Exploring the molecular mechanisms of PPARγ agonists in modulating memory impairment in neurodegenerative disorders;Molecular Biology Reports;2024-08-31

4. PRDM16-DT is a novel lncRNA that regulates astrocyte function in Alzheimer’s disease;Acta Neuropathologica;2024-08-29

5. True or false? Alzheimer’s disease is type 3 diabetes: Evidences from bench to bedside;Ageing Research Reviews;2024-08